CorVel Co. (NASDAQ:CRVL) Chairman V Gordon Clemons sold 3,000 shares of CorVel stock in a transaction on Tuesday, August 14th. The shares were sold at an average price of $57.60, for a total value of $172,800.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

V Gordon Clemons also recently made the following trade(s):

  • On Monday, August 6th, V Gordon Clemons sold 2,000 shares of CorVel stock. The shares were sold at an average price of $56.95, for a total value of $113,900.00.
  • On Wednesday, August 8th, V Gordon Clemons sold 2,929 shares of CorVel stock. The shares were sold at an average price of $56.87, for a total value of $166,572.23.
  • On Tuesday, July 17th, V Gordon Clemons sold 3,087 shares of CorVel stock. The shares were sold at an average price of $55.51, for a total value of $171,359.37.
  • On Friday, July 13th, V Gordon Clemons sold 5,250 shares of CorVel stock. The shares were sold at an average price of $56.18, for a total value of $294,945.00.
  • On Tuesday, July 10th, V Gordon Clemons sold 5,250 shares of CorVel stock. The shares were sold at an average price of $56.34, for a total value of $295,785.00.
  • On Monday, July 2nd, V Gordon Clemons sold 750 shares of CorVel stock. The shares were sold at an average price of $53.51, for a total value of $40,132.50.
  • On Thursday, July 5th, V Gordon Clemons sold 4,250 shares of CorVel stock. The shares were sold at an average price of $54.87, for a total value of $233,197.50.
  • On Friday, June 29th, V Gordon Clemons sold 2,450 shares of CorVel stock. The shares were sold at an average price of $54.25, for a total value of $132,912.50.
  • On Tuesday, June 26th, V Gordon Clemons sold 3,713 shares of CorVel stock. The shares were sold at an average price of $54.53, for a total value of $202,469.89.
  • On Thursday, June 21st, V Gordon Clemons sold 2,250 shares of CorVel stock. The shares were sold at an average price of $52.85, for a total value of $118,912.50.

NASDAQ:CRVL opened at $59.30 on Friday. CorVel Co. has a 52 week low of $46.45 and a 52 week high of $61.20. The firm has a market capitalization of $1.06 billion, a price-to-earnings ratio of 27.76 and a beta of 0.66.

CorVel (NASDAQ:CRVL) last issued its quarterly earnings data on Tuesday, July 31st. The business services provider reported $0.62 earnings per share for the quarter. CorVel had a return on equity of 23.42% and a net margin of 6.78%. The business had revenue of $150.40 million during the quarter.

Several hedge funds and other institutional investors have recently modified their holdings of the company. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp grew its stake in shares of CorVel by 15.1% in the second quarter. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp now owns 22,900 shares of the business services provider’s stock valued at $1,237,000 after buying an additional 3,000 shares in the last quarter. Raymond James & Associates grew its stake in shares of CorVel by 17.4% in the second quarter. Raymond James & Associates now owns 13,495 shares of the business services provider’s stock valued at $729,000 after buying an additional 2,002 shares in the last quarter. Legal & General Group Plc grew its stake in shares of CorVel by 4.7% in the second quarter. Legal & General Group Plc now owns 21,784 shares of the business services provider’s stock valued at $1,173,000 after buying an additional 979 shares in the last quarter. BlackRock Inc. grew its stake in shares of CorVel by 7.4% in the second quarter. BlackRock Inc. now owns 1,438,498 shares of the business services provider’s stock valued at $77,679,000 after buying an additional 98,761 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. grew its stake in shares of CorVel by 6.4% in the second quarter. Schwab Charles Investment Management Inc. now owns 48,095 shares of the business services provider’s stock valued at $2,598,000 after buying an additional 2,872 shares in the last quarter. 43.87% of the stock is owned by institutional investors and hedge funds.

Separately, BidaskClub upgraded CorVel from a “buy” rating to a “strong-buy” rating in a research report on Friday.

About CorVel

CorVel Corporation provides medical cost containment and managed care services to address the medical costs of workers' compensation benefits, automobile insurance claims, and group health insurance benefits. The company offers network solutions, including automated medical fee auditing, preferred provider management and reimbursement services, retrospective utilization review, facility claim review, professional review, pharmacy services, directed care services, medicare solutions, clearinghouse services, independent medical examinations, and inpatient medical bill review.

Featured Story: Book Value Per Share – BVPS

Insider Buying and Selling by Quarter for CorVel (NASDAQ:CRVL)

Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.